![](https://endpts.com/wp-content/uploads/2020/12/Wolfram-Carius-Bayer-tile-scaled.jpg)
Wolfram Carius, EVP Pharmaceuticals, Head of Cell & Gene Therapy (Bayer)
Bayer continues its cell and gene therapy push, enveloping different projects under one strategic roof while hunting new deals
Roughly five weeks after buying out Asklepios — also known as AskBio — for up to $4 billion, Bayer is hammering home its focus on cell …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.